HL GENOMICS Co., Ltd. (KOSDAQ:0156T0)
9,380.00
+280.00 (3.08%)
At close: Jul 31, 2026
HL GENOMICS Company Description
HL GENOMICS Co., Ltd. manufactures medicinal chemicals and antibiotics.
The company offers APIs (active pharmaceutical ingredients) and intermediates. The company was founded in 2000 and is based in Yongin, South Korea.
HL GENOMICS Co., Ltd. operates as a subsidiary of Hanlim Pharm.Co.,Ltd.
HL GENOMICS Co., Ltd.
| Country | South Korea |
| Founded | 2000 |
| Industry | Medicinal Chemicals and Botanical Products |
| CEO | Ho-Jin Kim |
Contact Details
Address: 1552 Bogaewonsam-ro Yongin-si, 17170 South Korea | |
| Phone | 82 3 1335 2080 |
| Website | hlgenomics.com |
Stock Details
| Ticker Symbol | 0156T0 |
| Exchange | KOSDAQ |
| Reporting Currency | KRW |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Ho-Jin Kim | Chief Executive Officer |
| Jong-su Park | Chief Financial Officer |